123 related articles for article (PubMed ID: 8092757)
1. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
[TBL] [Abstract][Full Text] [Related]
2. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormones and receptors in relation to S-phase fraction and ploidy level in endometrial carcinoma.
Boman K; Mäentausta O; Bäckström T; Strang P; Stendahl U
Anticancer Res; 1995; 15(3):999-1002. PubMed ID: 7645992
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry in uterine endometrial carcinoma.
Jacobsen M; Høyer M; Bentzen SM; Nielsen K
APMIS Suppl; 1991; 23():107-12. PubMed ID: 1883634
[TBL] [Abstract][Full Text] [Related]
6. [Degree of DNA ploidy and steroid hormone receptors as prognostic factors in endometrial carcinoma].
Köhler U; Martin R; Krug H; Bilek K
Zentralbl Gynakol; 1991; 113(20):1086-95. PubMed ID: 1746194
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of cell kinetic parameters of endometrial cancer].
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
[TBL] [Abstract][Full Text] [Related]
11. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.
Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS
Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072
[TBL] [Abstract][Full Text] [Related]
12. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
13. [Experimental and clinical study on flow cytometric DNA analysis of human breast carcinoma].
Nakamura A
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):737-46. PubMed ID: 3412305
[TBL] [Abstract][Full Text] [Related]
14. [Levels of estrogen and progesterone receptors in premalignant and malignant states in the endometrium].
Jokanović L; Cvrtila D; Klarić P; Kanajet D
Jugosl Ginekol Perinatol; 1991; 31(3-4):49-51. PubMed ID: 1749274
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
16. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
[TBL] [Abstract][Full Text] [Related]
17. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
[TBL] [Abstract][Full Text] [Related]
18. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
19. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
Köhler U; Krug H; Taubert G
Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
[TBL] [Abstract][Full Text] [Related]
20. Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma.
Ferrara F; De Santis L; Mangili F; Sassi I; Luchini S; Mandelli C; Santambrogio G; Cantaboni A
Pathol Res Pract; 1994 Nov; 190(11):1039-43. PubMed ID: 7746737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
